Site-specific effect of estradiol on gene expression in the adipose tissue of ob/ob mice

Hormone and Metabolic Research

Volumn 39, Issue 3, 2007, Pages 192-196

  Shinozaki, S ^a   Chiba, T ^a   Kokame, K ^b   Miyata, T ^b   Ai, M ^a   Kawakami, A ^a   Kaneko, E ^a   Yoshida, M ^a   Shimokado, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adipose tissue distribution; Estrogen; Estrogen receptors; Gene chip; Subcutaneous adipose tissue; Visceral adipose tissue

Indexed keywords

ANDROGEN RECEPTOR; DEAD BOX PROTEIN; ESTRADIOL; EUKARYOTIC INITIATION FACTOR 2 GAMMA Y; INITIATION FACTOR 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 2B; PHOSPHOGLYCERATE MUTASE; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN IIIB;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC SCREENING; INTRAABDOMINAL FAT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALS; CHEMOKINE CCL2; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, OBESE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RNA, MESSENGER; SEX CHARACTERISTICS; SUBCUTANEOUS FAT;

EUKARYOTA; MUS;

EID: 34147195508     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970417     Document Type: Article

References (34)

1. Björntorp P: The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1990; 20: 291-302
2. Couillard C, Bergeron N, Prud'homme D et al: Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999; 19: 2448-2455
3. Rodriguez-Cuenca S, Monjo M, Proenza AM, Roca P: Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am J Physiol Endocrinol Metabol 2005; 288: E200-E207
4. Roca P, Rodriguez AM, Oliver P et al: Brown adipose tissue response to cafeteria diet-feeding involves induction of the UCP2 gene and is impaired in female rats as compared to males. Pflugers Arch 1999; 438: 628-634
5. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS: Estrogen regulation of adiposity and fuel partitioning: Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005; 280: 35983-35991
6. Ohlsson C, Hellberg N, Parini P et al: Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 2000; 278: 640-645
7. Cooke PS, Naaz A: Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 2004; 229: 1127-1135
8. Morrisonb RF, Farmer SR: Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr 2000; 130: 3116S-3121S
9. Jones ME, Thorburn AW, Britt KL et al: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 2000; 97: 12735-12740
10. Brann DW L, Sevilla LD, Zamorano PL, Mahesh VB: Regulation of leptin gene expression and secretion by steroid hormones. Steroids 1999; 64: 659-663
11. Filardo EJ: Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002; 80: 231-238
12. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625-1630
13. Störk S, Baumann K, Schacky CV, Angerer P: The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res 2002; 53: 642-649
14. Pervin S, Singh R, Rosenfeld ME, Navab M, Chaudhuri G, Nathan L: Estradiol suppresses MCP-1 expression In vivo: implications for atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1575-1582
15. Malavazos AE, Cereda E, Morricone L, Coman C, Corsi MM, Ambrosi B: Monocyte chemoattractant protein-1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol 2005; 153: 871-877
16. Deo R, Khera A, McGuire DK et al: Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004; 44: 1812-1818
17. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K: Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 1999; 19: 1179-1182
18. Frazier-Jessen MR, Kovacs EJ: Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995; 154: 1838-1845
19. Seli E, Kayisli UA, Selam B, Seli M, Arici A: Estradiol suppresses vascular monocyte chemotactic protein-1 expression during early atherogenesis. Am J Obstet Gynecol 2002; 187: 1544-1549
20. Kanda N, Watanabe S: 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol 2003; 120: 1058-1066
21. Kovacs EJ, Faunce DE, Ramer-Quinn DS, Mott FJ, Dy PW, Frazier-Jessen MR: Estrogen regulation of JE/MCP-1 mRNA expression in fibroblasts. J Leukoc Biol 1996; 59: 562-568
22. Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein-1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003; 100: 7265-7270
23. Cardone A, Angelini F, Varriale B: Autoregulation of estrogen and androgen receptor mRNAs and downregulation of androgen receptor mRNA by estrogen in primary cultures of lizard testis cells. Gen Comp Endocrinol 1998; 110: 227-236
24. McAbee MD, Doncarlos LL: Estrogen, but not androgens, regulates androgen receptor messenger ribonucleic acid expression in the developing male rat forebrain. Endocrinology 1999; 140: 3674-3681
25. Fan W, Yanase T, Nomura M et al: Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 2005; 54: 1000-1008
26. Matsumoto T, Takeyama K, Sato T, Kato S: Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol 2003; 85: 95-99
27. Blouin K, Richard C, Bélanger C et al: Local androgen inactivation in abdominal visceral adipose tissue. J Clin Endocrinol Metab 2003; 88: 5944-5950
28. Dam KG, Breda E, Schaart G et al: Investigation of the expression and localization of glucose transporter 4 and fatty acid translocase/CD36 in equine skeletal muscle. Am J Vet Res 2004; 65: 951-956
29. Kell R, Pierce H, Swoap SJ: PGAM-M expression is regulated pretranslationally in hindlimb muscles and under altered loading conditions. J Appl Physiol 1999; 86: 236-242
30. Sakakibara K, Sato K, Yoshino K et al: Molecular identification and characterization of Xenopus egg uroplakin III, an egg raft-associated transmembrane protein that is tyrosine-phosphoryiated upon fertilization. J Biol Chem 2005; 280: 15029-15037
31. Ida K, Wada J, Zhang H et al: Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J Lipid Res 2000; 41: 1615-1622
32. Foresta C, Ferlin A, Moro E: Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet 2000; 9: 1161-1169
33. Ehrmann IE, Ellis PS, Mazeyrat S et al: Characterization of genes encoding translation initiation factor eIF-2gamma in mouse and human: sex chromosome localization, escape from X-inactivation and evolution. Hum Mol Genet 1998; 7: 1725-1737
34. Xu N, Tsai CL, Lee JT: Transient homologous chromosome pairing marks the onset of X inactivation. Science 2006; 311: 1149-1152